Size | Price | Stock | Qty |
---|---|---|---|
5mg |
|
||
10mg |
|
||
Other Sizes |
|
ln Vitro |
Beclomethasone dipropionate metabolism to 17-BMP is a crucial activation step. Beclomethasone 17-propionate suppresses TNFα, IL-6, and CXCL8 induced by LPS. Beclomethasone 17-propionate's EC50 values for TNFα, CXCL8, and IL-6 are 0.05 nM, 0.01 nM, and 0.1 nM, in that order. The GR-dependent genes FKBP51 and GILZ are upregulated in response to beclomethasone 17-propionate [3].
|
---|---|
References |
|
Additional Infomation |
An ester of beclomethasone.
See also: Beclomethasone Dipropionate (active moiety of). |
Molecular Formula |
C₂₅H₃₃CLO₆
|
---|---|
Molecular Weight |
464.98
|
Exact Mass |
464.197
|
CAS # |
5534-18-9
|
PubChem CID |
62965
|
Appearance |
White to off-white solid powder
|
Density |
1.3g/cm3
|
Boiling Point |
608.9ºC at 760mmHg
|
Melting Point |
124-126ºC
|
Flash Point |
322ºC
|
Index of Refraction |
1.583
|
LogP |
3.125
|
Hydrogen Bond Donor Count |
2
|
Hydrogen Bond Acceptor Count |
6
|
Rotatable Bond Count |
5
|
Heavy Atom Count |
32
|
Complexity |
925
|
Defined Atom Stereocenter Count |
8
|
SMILES |
CCC(=O)O[C@@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)Cl)O)C)C)C(=O)CO
|
InChi Key |
OHYGPBKGZGRQKT-XGQKBEPLSA-N
|
InChi Code |
InChI=1S/C25H33ClO6/c1-5-21(31)32-25(20(30)13-27)14(2)10-18-17-7-6-15-11-16(28)8-9-22(15,3)24(17,26)19(29)12-23(18,25)4/h8-9,11,14,17-19,27,29H,5-7,10,12-13H2,1-4H3/t14-,17-,18-,19-,22-,23-,24-,25-/m0/s1
|
Chemical Name |
[(8S,9R,10S,11S,13S,14S,16S,17R)-9-chloro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
|
Synonyms |
Beclomethasone 17propionate; Beclomethasone 17 propionate
|
HS Tariff Code |
2934.99.9001
|
Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture. |
Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
Solubility (In Vitro) |
DMSO : ~125 mg/mL (~268.83 mM)
|
---|---|
Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (5.38 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 2.1506 mL | 10.7532 mL | 21.5063 mL | |
5 mM | 0.4301 mL | 2.1506 mL | 4.3013 mL | |
10 mM | 0.2151 mL | 1.0753 mL | 2.1506 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.